Quantitative assessment of hepatitis B virus DNA during a 24-week course of lamivudine therapy

Ann Intern Med. 1998 Apr 15;128(8):697. doi: 10.7326/0003-4819-128-8-199804150-00028.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Antiviral Agents / administration & dosage*
  • DNA, Viral / blood*
  • Drug Administration Schedule
  • Hepatitis B / drug therapy*
  • Hepatitis B / virology
  • Humans
  • Lamivudine / administration & dosage*
  • Polymerase Chain Reaction

Substances

  • Antiviral Agents
  • DNA, Viral
  • Lamivudine